Literature DB >> 17299610

The effect of biliary sphincterotomy on serum cholesterol level in postcholecystectomy patients: a pilot study.

Waleed M Alazmi1, Evan L Fogel, James L Watkins, Lee McHenry, Stuart Sherman, Glen A Lehman.   

Abstract

BACKGROUND: Cholesterol, in the form of bile salts, is reabsorbed from the small intestine via the enterohepatic circulation. Biliary sphincterotomy increases the delivery of bile to the terminal ileum. If the absorptive capacity is exceeded, cholesterol excretion may increase, resulting in a decrease in serum cholesterol levels and improvement in serum lipid profiles. AIM: To determine the effect of biliary sphincterotomy on serum cholesterol levels in patients without biliary obstruction. PATIENTS AND METHODS: Postcholecystectomy patients with type III biliary sphincter of Oddi dysfunction (disabling pancreatobiliary-type pain with normal liver function tests and bile duct diameter) who underwent biliary sphincterotomy were identified retrospectively from the endoscopic retrograde cholangiopancreatography database. Baseline (pre-endoscopic retrograde cholangiopancreatography) laboratory investigations (including cholesterol) were obtained for all patients. The effect of sphincterotomy on total cholesterol levels was noted in all patients who returned for subsequent procedures (temporary pancreatic stent removal or evaluation of recurrent symptoms), and also in the subgroup of patients with baseline hypercholesterolemia (higher than 5.18 mmol/L).
RESULTS: In the present pilot study, the performance of biliary sphincterotomy was associated with a reduction in total serum cholesterol levels in postcholecystectomy patients without biliary obstruction. This was statistically significant in patients with a baseline cholesterol level higher than 5.18 mmol/L. A possible effect on low- and high-density lipoprotein concentrations was not evaluated. The influence of dietary changes and exercise were not accounted for.
CONCLUSION: A prospective, controlled study involving a larger series of patients is required to determine whether biliary sphincterotomy lowers cholesterol levels and improves lipid profiles.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17299610      PMCID: PMC2657665          DOI: 10.1155/2007/502931

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN: 0835-7900            Impact factor:   3.522


  29 in total

Review 1.  Drug treatment of lipid disorders.

Authors:  R H Knopp
Journal:  N Engl J Med       Date:  1999-08-12       Impact factor: 91.245

Review 2.  Clinical inquiries. What laboratory monitoring is appropriate to detect adverse drug reactions in patients on cholesterol-lowering agents?

Authors:  D Weismantel; P Danis
Journal:  J Fam Pract       Date:  2001-11       Impact factor: 0.493

3.  Three new drugs for hyperlipidemia.

Authors: 
Journal:  Med Lett Drugs Ther       Date:  2003-03-03       Impact factor: 1.909

4.  Ileal bile acid transport regulates bile acid pool, synthesis, and plasma cholesterol levels differently in cholesterol-fed rats and rabbits.

Authors:  G Xu; B L Shneider; S Shefer; L B Nguyen; A K Batta; G S Tint; M Arrese; S Thevananther; L Ma; S Stengelin; W Kramer; D Greenblatt; M Pcolinsky; G Salen
Journal:  J Lipid Res       Date:  2000-02       Impact factor: 5.922

5.  Bowel habit after cholecystectomy: physiological changes and clinical implications.

Authors:  J M Fort; F Azpiroz; F Casellas; J Andreu; J R Malagelada
Journal:  Gastroenterology       Date:  1996-09       Impact factor: 22.682

Review 6.  Surgical management of dyslipidemia: clinical and experimental evidence.

Authors:  M H Moghadasian; J J Frohlich; M Saleem; J M Hong; K Qayumi; C H Scudamore
Journal:  J Invest Surg       Date:  2001 Mar-Apr       Impact factor: 2.533

7.  Additive effects of Simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients.

Authors:  G Tonolo; M G Melis; M Formato; M F Angius; A Carboni; P Brizzi; M Ciccarese; G M Cherchi; M Maioli
Journal:  Eur J Clin Invest       Date:  2000-11       Impact factor: 4.686

8.  Long-term follow-up after endoscopic sphincterotomy for bile duct stones in patients younger than 60 years of age.

Authors:  J J Bergman; S van der Mey; E A Rauws; J G Tijssen; D J Gouma; G N Tytgat; K Huibregtse
Journal:  Gastrointest Endosc       Date:  1996-12       Impact factor: 9.427

9.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Authors:  J R Downs; M Clearfield; S Weis; E Whitney; D R Shapiro; P A Beere; A Langendorfer; E A Stein; W Kruyer; A M Gotto
Journal:  JAMA       Date:  1998-05-27       Impact factor: 56.272

10.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Authors: 
Journal:  Lancet       Date:  2002-07-06       Impact factor: 79.321

View more
  2 in total

1.  Cholecystectomy and Biliary Sphincterotomy Increase Fecal Bile Loss and Improve Lipid Profile in Dyslipidemia.

Authors:  Ilia Sergeev; Nirit Keren; Timna Naftali; Fred M Konikoff
Journal:  Dig Dis Sci       Date:  2019-09-14       Impact factor: 3.199

2.  Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare.

Authors:  Jessica L Petrick; Baiyu Yang; Sean F Altekruse; Alison L Van Dyke; Jill Koshiol; Barry I Graubard; Katherine A McGlynn
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.